https://seekingalpha.com/article/4679248-healthequity-inc-hqy-q4-2024-earnings-call-transcript?source=feed_sector_transcripts
Mar 19, 2024 - HealthEquity, Inc. (NASDAQ:NASDAQ:HQY) Q4 2024 Results Conference Call March 19, 2024 4:30 PM ETCompany ParticipantsRichard Putnam - Investor RelationsJon...
0
sa:3799115746105062881
0
https://www.zacks.com/stock/news/2243114/compared-to-estimates-healthequity-hqy-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2243114
Mar 19, 2024 - The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:8540669521700491736
0
https://www.zacks.com/stock/news/2242869/here-s-why-you-should-retain-healthequity-hqy-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242869
Mar 19, 2024 - HealthEquity's (HQY) strength in HSAs raises optimism about the stock.
zc:7712319095030402645
0
https://www.zacks.com/stock/news/2241382/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2241382
Mar 15, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zc:-4086040377222955638
0
https://www.zacks.com/stock/news/2239310/healthequity-hqy-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2239310
Mar 12, 2024 - HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-5062835243638069446
0
https://www.zacks.com/stock/news/2234658/why-healthequity-hqy-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2234658
Mar 01, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:-426458265280102149
0
https://www.zacks.com/stock/news/2232650/why-healthequity-hqy-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2232650
Feb 27, 2024 - HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:832671697970919989
0
https://www.zacks.com/commentary/2224052/3-medical-services-stocks-to-buy-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2224052
Feb 09, 2024 - The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most. However, staffing shortages continue to disrupt the growth trend.
zc:-5665982398767085151
0
https://www.zacks.com/stock/news/2216440/healthequity-inc-hqy-hit-a-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-2216440
Jan 26, 2024 - HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
zc:-5148480899851748366
0
https://www.zacks.com/stock/news/2212281/penumbra-pen-rides-on-vascular-arm-strength-amid-fx-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2212281
Jan 18, 2024 - Penumbra's (PEN) Vascular business is demonstrating strong growth, banking on a rapid increase in sales of vascular thrombectomy products in the United States.
zc:1344420748921052212
0